Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.05 USD | -1.95% | +3.08% | +27.60% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.60% | 2.27B | |
+10.29% | 3,082B | |
+8.12% | 84.92B | |
+5.55% | 78.23B | |
-13.73% | 54.06B | |
+19.98% | 45.87B | |
-24.43% | 46.79B | |
+21.26% | 42.65B | |
+60.27% | 37.28B | |
-9.36% | 24.89B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite Sees Improved Business Momentum in 2024, BofA Securities Says